Medical Xpress

NOVEMBER 25, 2022

A team of researchers at Duke University has developed a vaccine against uropathogenic E. coli (UPEC), the type of bacteria that cause urinary tract infections (UTIs) in humans.

Bacteria 98

Bacteria Vaccination Vaccine Development 98

XTalks

MAY 11, 2023

Cronobacter sakazakii , the bacteria linked to recent baby formula shortages and the Abbott infant formula recall, could soon join the federal disease watchlist. Also known as Enterobacter sakazakii , Cronobacter sakazakii is a bacteria that can cause severe infections, particularly in infants, and is associated with high mortality rates.

Bacteria 98

Bacteria Doctors Doctor Contamination 98

Medical Xpress

JANUARY 4, 2023

One type of bacteria found in the gut may contribute to the development of Type 2 diabetes, while another may protect from the disease, according to early results from an ongoing, prospective study led by investigators at Cedars-Sinai.

Bacteria 75

Bacteria Development 75

Drug Discovery World

JANUARY 8, 2024

“New antibiotics directed against the world’s highest priority bacteria, like Acinetobacter baumannii , require novel development paths. It inhibits the LptB2FGC complex, the machinery that assembles the outer membrane of gram-negative bacteria.

Bacteria 52

Bacteria Drugs Clinical Trials Clinical Trials 52

Medical Xpress

DECEMBER 7, 2022

Bacteria known to cause oral infections may also be a contributory factor in patients developing potentially life-threatening abscesses on the brain, new research has shown.

Bacteria 70

Bacteria Development Research 70

ProRelix Research

SEPTEMBER 7, 2023

Autoimmune disorders comprise several diseases in which the immune system mistakenly attacks and destroys the body’s own healthy cells instead of destroying bacteria and viruses to keep the body healthy. […] The post Autoimmune disorders and current developments of novel treatments under clinical trials appeared first on ProRelix Research.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Development 105

Bio Pharma Dive

AUGUST 24, 2022

The New York biotech will invest in and develop up to three drugs with Gensaic, an emerging startup aiming to use the viruses that infect bacteria to deliver genetic medicines.

Gene Therapy 279

Gene Therapy Bacteria Gene Drugs 279

Drug Discovery World

AUGUST 7, 2023

The results suggest TC1 has potential to inhibit the development of all malaria parasites which affect humans (P. ” Edited by: Diana Spencer, Senior Digital Content Editor, Drug Discovery World The post Newly-discovered bacteria could prevent malaria appeared first on Drug Discovery World (DDW). ovale and P. falciparum).

Bacteria 52

Bacteria Bacterium Containment Scientist 52

Scienmag

OCTOBER 14, 2021

In the fight against multidrug-resistant bacteria, scientists in Sweden have developed a new kind of antibiotic-free protection for wounds that kills drug-resistant bacteria and induces the body’s own immune responses to fight infections.

Bacteria 52

Bacteria Immune Response Drugs Scientist 52

Pharmaceutical Technology

OCTOBER 6, 2022

from the US National Institutes of Health (NIH) unit National Institute of Allergy and Infectious Diseases (NIAID) to develop a prophylactic intranasal vaccine against Neisseria gonorrhoeae (NG). Leveraging its outer membrane vesicles (OMV) platform technology, Intravacc will develop the vaccine.

Vaccination 147

Vaccination Vaccine Development Bacterium 147

XTalks

JULY 31, 2020

A study published in Nature on July 30, 2020 states that good bacteria living in our gut can do much more than just help digest food and boost our immune system. According to studies conducted by researchers at Cincinnati Children’s Hospital, the bacteria can help heal damaged intestinal tissues.

Bacteria 98

Bacteria Genetic Engineering Engineer Research 98

BioPharma Reporter

NOVEMBER 14, 2023

Glox Therapeutics, a company developing precision antibiotic therapies based on naturally occurring bacteriocins, has raised Â4.3m in seed funding to develop targeted therapeutics against antibiotic-resistant Gram-negative bacteria.

Development 52

Development Bacteria Regulation Marketing 52

Scienmag

DECEMBER 10, 2020

The research, involving URV researcher Vladimir Baulin, opens the door to the development of new bactericide materials as an alternative to antibiotics Credit: Vladimir Baulin Finding alternatives to antibiotics is one of the biggest challenges facing the research community.

Bacteria 96

Bacteria Research Development Drugs 96

Bio Pharma Dive

FEBRUARY 26, 2024

The drug, one of several GSK is developing for drug-resistant bacteria, has now succeeded in testing against two different infections.

Bacteria 148

Bacteria Drugs Development 148

Pharmaceutical Technology

FEBRUARY 2, 2023

The University of Texas MD Anderson Cancer Center has announced a strategic collaboration with Federation Bio for the development of a new microbiome treatment for immunotherapy-resistant cancer patients. The post MD Anderson partners with Federation Bio to develop microbiome therapy appeared first on Pharmaceutical Technology.

Development 130

Development Manufacturing Bacteria Production 130

Scienmag

SEPTEMBER 16, 2021

engineers and chemists has taken a major step forward in the development of?microbial?fuel natural bacteria to extract electrons from organic matter in wastewater to generate electrical currents.?A fuel cells — a technology that?utilizes?natural A study detailing the breakthrough was recently published in?Science.?

Bacteria 68

Bacteria Engineer Research Development 68

Scienmag

MARCH 25, 2022

Scientists at Nanyang Technological University, Singapore (NTU Singapore) have developed probiotics with a unique edible coating that ensures the beneficial bacteria successfully reach the intestine once they are ingested.

Scientist 90

Scientist Bacteria Development 90

Scienmag

FEBRUARY 25, 2021

But viruses can also infect life-sustaining bacteria and a Johns Hopkins University-led team has developed a test to determine if bacteria are sick, similar to the one used to test humans for COVID-19. The pandemic has made clear the threat that some viruses pose to people.

Bacteria 40

Bacteria Development Engineer 40

Scienmag

MAY 10, 2021

First successful implementation of new antibacterial technology Credit: Anna-Lena Lundqvist/Chalmers Researchers at Chalmers University of Technology, Sweden, have developed a new material that prevents infections in wounds – a specially designed hydrogel, that works against all types of bacteria, including antibiotic-resistant ones.

Bacteria 70

Bacteria Development Research 70

BioTech 365

DECEMBER 1, 2020

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Researchers develop customized targeting of bacteria using lysins.Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for Research and Technology (SMART), MIT’s (..)

Bacteria 40

Bacteria Development Research 40

The Pharma Data

MARCH 18, 2022

Columbia Engineering researchers report that they have developed a “cloaking” system that temporarily hides therapeutic bacteria from immune systems, enabling them to more effectively deliver drugs to tumors and kill cancer cells in mice. Using Bacteria For Therapy. Sheng Professor of Biomedical Engineering.

Bacteria 52

Bacteria Engineer Drugs Research 52

Medical Xpress

MAY 9, 2023

Clostridioides difficile infection causes severe diarrhea and results in the death of nearly 20,000 patients in Europe each year. It is one of the most common hospital-acquired infections. When it relapses, the disease must be treated by fecal microbiota transplantation.

Bacteria 90

Bacteria Development 90

Outsourcing Pharma

SEPTEMBER 11, 2023

million seed funding round to develop its point-of-care diagnostic platform, which can confirm the presence of bacteria and rapidly identify effective antibiotics to use and which ones to avoid. Glasgow diagnostics spinout Microplate Dx has closed a Â2.5

Development 52

Development Bacteria Clinical Development 52

Drug Discovery World

NOVEMBER 16, 2023

Glox Therapeutics has raised £4.3M ($5.2M) in seed funding to develop targeted therapeutics against antibiotic-resistant Gram-negative bacteria. The company will use the funding to establish laboratories in Oxford and Glasgow and expand its team to accelerate its bacteriocin development programme.

Development 52

Development Bacteria Life Science Engineer 52

Scienmag

AUGUST 14, 2020

– Scientists have found clear indicators for how the interaction of poor hygiene and antibiotic use contribute to the colonization of antimicrobial-resistant (AMR) bacteria in humans, a problem that contributes to hundreds of thousands of deaths annually. Credit: WSU PULLMAN, Wash. Allen School for Global […].

Bacteria 86

Bacteria Scientist Research Development 86

Scienmag

JULY 13, 2022

Credit: NTU Singapore Singapore Centre for Environmental Life […].

Bacteria 69

Bacteria Scientist Life Science Engineer 69

Pharmaceutical Technology

DECEMBER 21, 2023

This innovative composition induces a protective immune response against Group A Streptococcus (GAS) bacteria, offering potential targets for vaccine development. Discover a groundbreaking immunogenic composition patent that combines GAS polypeptide antigens and polypeptide-polysaccharide conjugates.

Immune Response 100

Immune Response Bacteria Vaccination Vaccine 100

Scienmag

SEPTEMBER 8, 2020

Credit: Avalos Lab/Princeton University Researchers at Princeton University have created a new and improved way to more precisely control genetically engineered bacteria: by simply switching the lights on and off. Working in E.

Bacteria 56

Bacteria Genetic Engineering Engineer Genetics 56

AuroBlog - Aurous Healthcare Clinical Trials blog

SEPTEMBER 22, 2022

The research involves using spherical vesicles secreted by bacteria coated on gold nanoparticles which can then be delivered to the immune cells. The Indian Institute of Science (IISc), Centre for BioSystems Science and Engineering, has designed a new method to deliver a vaccine candidate for tuberculosis (TB).

Vaccination 100

Vaccination Vaccine Research Bacteria 100

Scienmag

NOVEMBER 24, 2020

A Canadian team from INRS has demonstrated the effectiveness of an inexpensive molecule to fight antibiotic-resistant strains of the bacteria responsible for gonorrhea and meningococcal meningitis Credit: INRS A team from the Institut national de la recherche scientifique (INRS) has demonstrated the effectiveness of an inexpensive molecule to fight (..)

Bacteria 52

Bacteria Development Medicine 52

Drug Discovery World

NOVEMBER 4, 2022

New research has furthered our understanding of the immune-related factors that drive infection and disease, which will be necessary for an effective tuberculosis (TB) vaccine to be developed. infection in infants who became infected with the bacteria but did not progress to active TB. Most individuals infected with M.tb

Vaccination 52

Vaccination Vaccine Development Bacteria 52

Scienmag

JANUARY 5, 2022

. – Immunologists have long been baffled by LPS, the bacterial lipopolysaccharide that helps form the cell walls of Gram-negative bacteria. Immunologists have long been baffled by LPS, the bacterial lipopolysaccharide that helps form the cell walls of Gram-negative bacteria. Credit: UAB BIRMINGHAM, Ala.

Bacteria 89

Bacteria Development Medicine 89

Scienmag

APRIL 2, 2021

It allows to kill bacteria and to raise healthy chickens with less dose of antibiotics Credit: UrFU / Ilya Safarov. Russian researchers have developed an inexpensive, safe, and reliable packed eggs surface disinfection technology. This technology helps to kill bacteria, including salmonella, on eggshells.

Bacteria 66

Bacteria Development Scientist Research 66

Scienmag

MAY 4, 2021

Investigators found similarities in the bacterial composition of the mouth among patients with early rheumatoid arthritis and those at risk of developing the disease, compared with healthy individuals who were not at risk. The findings come from a study published in Arthritis & Rheumatology.

Bacteria 57

Bacteria Development Allergies Medicine 57

BioTech 365

SEPTEMBER 18, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Yeast and bacteria together biosynthesize plant hormones for weed control.Plants regulate their growth and development using hormones, including a group called strigolactones that prevent excessive budding and … Continue (..)

Hormones 40

Hormones Bacteria Regulation Development 40

STAT News

NOVEMBER 30, 2022

The Food and Drug Administration approved the first therapy using bacteria from stool samples to treat a bowel disorder on Wednesday, paving the way for several similar treatments in development.  in which the toxin-producing bacteria disrupts the normal balance in a person’s digestive system.

FDA Approval 116

FDA Approval Bacteria Drugs Development 116

Pharmaceutical Technology

DECEMBER 14, 2022

Antibiotics are the go-to treatment for bacterial infections in developed countries, such as Strep A. Bacteria naturally develop resistance to antibiotics over time, through genetic mutation, horizontal gene transfer between bacteria, or because of selective pressure. Virus versus bacteria.

Bacteria 130

Bacteria DNA Clinical Trials Clinical Trials 130